Back to WELLINGTON MANAGEMENT GROUP LLP

CLDX
Showing 8 of 14 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in CELLDEX THERAPEUTICS INC NEW

WELLINGTON MANAGEMENT GROUP LLP holds 8.6M shares of CLDX (CELLDEX THERAPEUTICS INC NEW), worth $271.5M as of 2026-Q1. The position was increased (+6.0% shares). CLDX represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$271.5M

Current Shares

8.6M

Total Value Change

-$27.4M

Total Shares Change

+484,536

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
8.6M
+6.0%
$271.5M0.1%$28.94
33
2025-Q4
Increased
8.1M
+39.3%
$219.4M0.0%$26.43
40
2025-Q3
Increased
5.8M
+10.8%
$150M0.0%$26.19
34
2025-Q2
Decreased
5.2M
-37.4%
$106.5M0.0%$20.29
0
2025-Q1
Decreased
8.4M
-6.9%
$151.6M0.0%$19.93
0
2024-Q4
Decreased
9M
-2.9%
$226.8M0.0%$25.12
0
2024-Q3
Increased
9.2M
+14.5%
$314.2M0.1%$33.20
35
2024-Q2
Increased
8.1M
+5.6%
$298.9M0.1%$37.01
33

Other major holders of CLDX: RTW INVESTMENTS, LP, BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used